Why Neurocrine Biosciences, Inc. (NBIX) stock moved
Neurocrine Biosciences, Inc. (NBIX) shares climbed 13.8% to $165.48 as of November 3, 2026, a sharp gain from the prior close of $145.35. BestStocks flagged the session as a major change for NBIX. Below, we break down what changed for NBIX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
NBIX climbed 13.8% to $165.48
Neurocrine Biosciences (NBIX) surged 14.05% to $165.77 following an earnings report and material event filing (8-K) disclosed today, according to SEC filings and earnings event records. The concrete driver remains the filed 8-K and earnings announcement; details of the specific news are not yet available in the provided evidence. Review the full 8-K (nbix-20261102.htm) and earnings release for specific guidance, pipeline updates, or corporate actions driving the gain; monitor for analyst reaction and any earnings call scheduled.
What it means for Neurocrine Biosciences, Inc. investors
For Neurocrine Biosciences, Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Earnings beat with positive market reaction; Strong 13.8% price move on light volume. Weighing against that: Neurocrine Biosciences fell 3.11% to $136.97 ahead of third-quarter 2026 earnings on October 27, with the company having announced its earnings call for November 2 on October 12 (PRNewswire). Wall Street's consensus price target sits at $204.18, implying +23.4% upside from $165.48. BestStocks rates the overall signal quality low (57/100). With earnings roughly 99 days out, the next report is the most likely near-term test of the move.
NBIX price reaction
NBIX last traded at $165.48, up $20.13 (+13.85%) from the previous close of $145.35. The session traded on 0.8× average volume (below avg), so participation was unremarkable.
Bullish and bearish analyst opinions on Neurocrine Biosciences, Inc. (NBIX)
The consensus analyst price target on Neurocrine Biosciences, Inc. (NBIX) is $204.18, 23.4% above the recent $165.48. Over the past 90 days analysts logged 0 upgrades, 7 maintains, and 0 downgrades. Here is how the bullish and bearish cases on NBIX line up.
The bullish case
- Wall Street's consensus price target of $204.18 implies +23.4% upside from $165.48.
- The Street's most bullish target is $230.00 (+39.0%).
- Earnings beat with positive market reaction.
- Strong 13.8% price move on light volume.
- Neurocrine Biosciences (NBIX) surged 14.05% to $165.77 following an earnings report and material event filing (8-K) disclosed today, according to SEC filings and earnings event records.
The bearish case
- The most bearish analyst target is $165.00 (-0.3%).
- Neurocrine Biosciences fell 3.11% to $136.97 ahead of third-quarter 2026 earnings on October 27, with the company having announced its earnings call for November 2 on October 12 (PRNewswire).
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 3, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for NBIX
In-depth NBIX event analyses
Frequently asked questions about NBIX
Why did Neurocrine Biosciences, Inc. (NBIX) stock move?
NBIX climbed 13.8% to $165.48. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did NBIX stock rise?
NBIX gained 13.85% ($20.13) versus the prior close of $145.35, last trading at $165.48 on 0.8× average volume.
When is Neurocrine Biosciences, Inc.'s next earnings date?
NBIX's next earnings report is estimated for 2027-02-10 — about 99 days away.
What is the analyst price target for NBIX?
The consensus analyst price target for NBIX is $204.18, about 23.4% above the current $165.48. Over the past 90 days, analysts recorded 0 upgrades, 7 maintains, and 0 downgrades.
How BestStocks tracks NBIX
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared NBIX-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for NBIX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 3, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.